当前位置: 首页 > 期刊 > 《中国现代医生》 > 2018年第8期
编号:13234349
耐碳青霉烯类肺炎克雷伯菌相关危险因素及防治研究进展(5)
http://www.100md.com 2018年3月15日 《中国现代医生》 2018年第8期
     [28]Di X,Wang R,Liu B,et al. In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa[J].J Antibiot,2015,68(9):551-555.

    [29]Souli M,Galani I,Boukovalas S. In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniaea protection of resistancedevelopment[J].Antimicrob Agents Chemother,2011, 55(5):2395-2397.

    [30]李林,張晓芬,张建,等.磷霉素治疗耐碳青霉烯-肺炎克雷伯菌感染11例疗效观察[J].中国药业,2015,(13):78-79.

    [31]Yow CM,Fung K,Wong KC.Photodynamic inactivation ofmulti-drug resistant pathogens in Hong Kong[J]. Hong Kong Med J,2011,17(2):24-28.

    [32]Liu C,Zhou Y,Wang L,et al.Photodynamic inactivation of Klebsiella pneumoniae biofilms and planktonic cells by 5-aminolevulinic acid and 5-aminolevulinic acid methyl ester[J].Lasers Med Sci,2016,31(3):557-565.

    [33]St Denis TG,Dai T,Izikson L,et al. All you need is light:Antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease[J].Virulence,2011,2(6):509-520.

    (收稿日期:2017-11-14), 百拇医药(洪佳莉 吴军华 邱海燕)
上一页1 2 3 4 5